Derivation and validation of a disease-specific risk score for cardiac risk stratification in chronic kidney disease

Kirsten A Armstrong1, Dhrubo J Rakhit, Colin Case

  • 1MBBS, University of Queensland, Department of Medicine, Princess Alexandra Hospital, Ipswich Road, Brisbane, Queensland 4102, Australia.

Insights

A new cardiac risk score effectively identifies patients with chronic kidney disease (CKD) at high risk for cardiac events. This score uses cardiac history, dialysis duration, BMI, and phosphate levels for improved risk stratification.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Risk Prediction

Background:

  • Cardiac events are a leading cause of mortality in chronic kidney disease (CKD) patients.
  • Accurate risk stratification is crucial for managing cardiovascular complications in CKD.

Purpose of the Study:

  • To develop and validate a novel cardiac risk score for predicting cardiac events in CKD patients.
  • To identify key clinical and biochemical factors associated with cardiac events in this population.

Main Methods:

  • A cardiac risk score was derived using Cox regression analysis in 167 CKD patients.
  • Independent predictors included cardiac history, body mass index (BMI), dialysis duration, and serum phosphate.
  • The score's validity was confirmed in a separate validation cohort of 99 CKD patients.

Main Results:

  • The derived cardiac risk score demonstrated strong predictive performance (AUC 0.86 in derivation, 0.84 in validation).
  • Key predictors identified were cardiac history, BMI, dialysis duration, and serum phosphate.
  • An optimal cut-off identified high-risk individuals, who experienced significantly more cardiac events.

Conclusions:

  • A validated cardiac risk score incorporating cardiac history, dialysis duration, BMI, and phosphate effectively identifies CKD patients at risk of future cardiac events.
  • This tool can aid in risk stratification and clinical decision-making for CKD patients.
  • Further application of this score may improve cardiovascular outcomes in CKD management.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...